Netarsudil Mesylate Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 1 pharmaceutical company such as ALCON LABS INC. It is marketed under 1 brand name, including RHOPRESSA. Available in 1 different strength, such as EQ 0.02% BASE, and administered through 1 route including SOLUTION/DROPS;OPHTHALMIC.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"40908","ingredient":"NETARSUDIL MESYLATE","trade_name":"RHOPRESSA","family_id":"af6c2649d1094358ad80","publication_number":"US8450344B2","cleaned_patent_number":"8450344","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-07-11","publication_date":"2013-05-28","legal_status":"Granted"} US8450344B2 Molecular Formulation 28 May, 2013 Granted 11 Jul, 2026
{"application_id":"40922","ingredient":"NETARSUDIL MESYLATE","trade_name":"RHOPRESSA","family_id":"af6c2649d1094358ad80","publication_number":"US11021456B2","cleaned_patent_number":"11021456","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-07-11","publication_date":"2021-06-01","legal_status":"Granted"} US11021456B2 01 Jun, 2021 Granted 11 Jul, 2026
{"application_id":"40916","ingredient":"NETARSUDIL MESYLATE","trade_name":"RHOPRESSA","family_id":"af6c2649d1094358ad80","publication_number":"US9096569B2","cleaned_patent_number":"9096569","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-07-11","publication_date":"2015-08-04","legal_status":"Granted"} US9096569B2 Molecular Formulation 04 Aug, 2015 Granted 11 Jul, 2026
{"application_id":"40920","ingredient":"NETARSUDIL MESYLATE","trade_name":"RHOPRESSA","family_id":"af6c2649d1094358ad80","publication_number":"US10532993B2","cleaned_patent_number":"10532993","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-07-11","publication_date":"2020-01-14","legal_status":"Granted"} US10532993B2 14 Jan, 2020 Granted 11 Jul, 2026
{"application_id":"40921","ingredient":"NETARSUDIL MESYLATE","trade_name":"RHOPRESSA","family_id":"af6c2649d1094358ad80","publication_number":"US10882840B2","cleaned_patent_number":"10882840","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-07-11","publication_date":"2021-01-05","legal_status":"Granted"} US10882840B2 05 Jan, 2021 Granted 11 Jul, 2026
{"application_id":"37419","ingredient":"NETARSUDIL MESYLATE","trade_name":"RHOPRESSA","family_id":"d677d43a6e4546a98867","publication_number":"US10174017B2","cleaned_patent_number":"10174017","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-01-27","publication_date":"2019-01-08","legal_status":"Granted"} US10174017B2 Molecular Formulation 08 Jan, 2019 Granted 27 Jan, 2030
{"application_id":"37421","ingredient":"NETARSUDIL MESYLATE","trade_name":"RHOPRESSA","family_id":"d677d43a6e4546a98867","publication_number":"US10654844B2","cleaned_patent_number":"10654844","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-01-27","publication_date":"2020-05-19","legal_status":"Granted"} US10654844B2 Molecular Formulation 19 May, 2020 Granted 27 Jan, 2030
{"application_id":"37422","ingredient":"NETARSUDIL MESYLATE","trade_name":"RHOPRESSA","family_id":"d677d43a6e4546a98867","publication_number":"US11028081B2","cleaned_patent_number":"11028081","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-01-27","publication_date":"2021-06-08","legal_status":"Granted"} US11028081B2 08 Jun, 2021 Granted 27 Jan, 2030
{"application_id":"23485","ingredient":"NETARSUDIL MESYLATE","trade_name":"RHOPRESSA","family_id":"7dfa0d36638342a88505","publication_number":"US11618748B2","cleaned_patent_number":"11618748","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-01-27","publication_date":"2023-04-04","legal_status":"Granted"} US11618748B2 04 Apr, 2023 Granted 27 Jan, 2030
{"application_id":"37413","ingredient":"NETARSUDIL MESYLATE","trade_name":"RHOPRESSA","family_id":"d677d43a6e4546a98867","publication_number":"US8394826B2","cleaned_patent_number":"8394826","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-10","publication_date":"2013-03-12","legal_status":"Granted"} US8394826B2 Molecular Formulation 12 Mar, 2013 Granted 10 Nov, 2030
{"application_id":"35323","ingredient":"NETARSUDIL MESYLATE","trade_name":"RHOPRESSA","family_id":"27c33da3bc144ecc8603","publication_number":"US9931336B2","cleaned_patent_number":"9931336","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-03-14","publication_date":"2018-04-03","legal_status":"Granted"} US9931336B2 Molecular Formulation 03 Apr, 2018 Granted 14 Mar, 2034
{"application_id":"35327","ingredient":"NETARSUDIL MESYLATE","trade_name":"RHOPRESSA","family_id":"27c33da3bc144ecc8603","publication_number":"US11020385B2","cleaned_patent_number":"11020385","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-03-14","publication_date":"2021-06-01","legal_status":"Granted"} US11020385B2 01 Jun, 2021 Granted 14 Mar, 2034
{"application_id":"35326","ingredient":"NETARSUDIL MESYLATE","trade_name":"RHOPRESSA","family_id":"27c33da3bc144ecc8603","publication_number":"US10588901B2","cleaned_patent_number":"10588901","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-03-14","publication_date":"2020-03-17","legal_status":"Granted"} US10588901B2 Molecular Formulation 17 Mar, 2020 Granted 14 Mar, 2034
{"application_id":"35320","ingredient":"NETARSUDIL MESYLATE","trade_name":"RHOPRESSA","family_id":"27c33da3bc144ecc8603","publication_number":"US9415043B2","cleaned_patent_number":"9415043","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-03-14","publication_date":"2016-08-16","legal_status":"Granted"} US9415043B2 Molecular 16 Aug, 2016 Granted 14 Mar, 2034
{"application_id":"35328","ingredient":"NETARSUDIL MESYLATE","trade_name":"RHOPRESSA","family_id":"27c33da3bc144ecc8603","publication_number":"US11185538B2","cleaned_patent_number":"11185538","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-03-14","publication_date":"2021-11-30","legal_status":"Granted"} US11185538B2 Formulation 30 Nov, 2021 Granted 14 Mar, 2034

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Netarsudil Mesylate

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.